Autopbsct ガイドライン
WebMar 6, 1998 · In order to determine if peripheral blood stem cells (PBSC) collected after priming with G-CSF in AML in first complete remission (CR) can be used for autologous … Web2 非血縁者間pbsct導入の意義 •非血縁者間pbsctは諸外国では約10年前から広く行われて おり、国内でも血縁者間では既に実施されている。
Autopbsct ガイドライン
Did you know?
Web4 52 F AML (M4), first CR autoPBSCT Day 25 Cytomegalovirus Dead (day 171) 4 5 43 F Subcutaneous NHL autoPBSCT Day 130 Clonal evolution Dead (day 167) 5 (B cell), second CR in lymphoma cells 6 40 F APL, fourth CR uBMT Day 59 Cytomegalovirus Dead (day 64) 6 7 26 F AML (M4), first CR uBMT Day 286 EB virus Dead (day 302) 7 WebNational Center for Biotechnology Information
WebNov 16, 2004 · Lower Relapse Incidence after Non-Cryopreserved Autologous Bone Marrow Transplantation Compared to Peripheral Blood Stem Cell Transplantation for High-Risk Hodgkin’s Lymphoma. Blood American Society of Hematology Abstract. WebNov 16, 2004 · Late Consolidation for Patients with Standard Risk AML up to 60 Years: Results of a Prospective Randomized Comparison of High Dose AraC and Autologous PBSCT. Blood American Society of Hematology Abstract. 421 patients (pts.) up to 60 years with de novo (n=328) or secondary (n=93) AML were treated with risk-adapted …
WebApr 11, 2001 · Period of neutropenia was 15 days for AlloPBSCT and 12 days for AutoPBSCT. The microbiological identification rate was 47% (32/68). Gram-positive infections dominated the early period (50%) and... WebNov 16, 2004 · The neutrophil >0.5 G/L recovery was faster in the autoPBSCT group compared with autoBMT (14.7 vs. 17 d., p=0.006) whereas the difference regarding platelet >50 G/L recovery was not significant (17.5 vs. 19 d., p=NS). Both procedures did not differ in terms of severe adverse events as well as the need for blood products substitution, iv ...
WebSep 2, 2012 · Moreover, autoPBSCT resulted in complete remission of pyoderma gangraenosum in patient #8 and of fistulising disease in patient #7. Interestingly, patient #11 experienced several flares of CD-related arthritis with only minor concomitant intestinal symptoms, suggesting the organ involvement of CD may also be altered following …
WebAims: Autologous peripheral blood stem cell transplantation (autoPBSCT) is increasingly and successfully applied to patients with treatment-resistant autoimmune diseases, … tardes ikea almeriaWebMar 31, 2016 · Guidelines from the European Association of Neuro-Oncology consider up-front HDC/ASCT as an experimental treatment in PCNSL, 4 whereas National Comprehensive Cancer Network guidelines for routine practice refers to HDC/ASCT as an alternative to WBRT in patients who achieve CR after HD-MTX–containing induction. 14 tarc tuscaloosaWeb社会福祉法人 恩賜財団 済生会 tardets mauleon busWebJul 17, 2000 · This study was undertaken to compare infections and the outcome after conventional chemotherapy (CCT), allogeneic PBSC transplantation (alloPBSCT) or autologous PBSC transplantation (autoPBSCT),... bric brac ravennaWebNov 16, 2012 · European Group for Bone Marrow transplant (EBMT) risk score is a validated predictor of outcome for patients undergoing allo-HCT for hematological malignancies. It takes into consideration patient's age, donor's gender and type, disease status and the interval from diagnosis to allo-HCT, with the score ranging from 0 to 7. brice 330iksaWebMay 29, 2024 · ALCL, ALK-; anaplastic large cell lymphoma, ALK-negative, ALCL, ALK+; anaplastic large cell lymphoma, ALK-positive, autoPBSCT; autologous peripheral blood stem cell transplantation, ECOG; Eastern Cooperative Oncology Group, ENKTL; extranodal NK/T cell lymphoma, nasal type, GI; gastrointestinal tract, IPI; Interna- tional prognostic … bric brazilWebautoPBSCT) for Korean patients with high-risk ESFT. We reviewed the data from children and adults with ESFT who received HDCT/ autoPBSCT at the Korea Cancer Center Hospital, who had 1) recurrent tumors, 2) metastatic disease at the time of diagnosis, or 3) a centrally located tumor. We analyzed the clinicopathologic bricco\\u0027s akron